2021年10期
刊物介绍
本刊主要出版来自成年神经元的转化与再生；损伤神经元的轴突和树突的修复与再生；神经再生过程中神经元、微环境、新生血管的变化；神经损伤后的干预、修复、保护与再生的组织形态学变化乃至细胞生物学或细胞分子生物学的改变；神经再生研究中的新理论、新技术、新方法。NRR杂志希望成为国际神经再生领域读者、作者和专业学者最喜欢、最认可的优秀的专业性学术期刊。 br 期刊官方网站： (英文)； （中文） br 期刊投稿网站：
中国神经再生研究（英文版）
- Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders
- The role of gap junctions in cell death and neuromodulation in the retina
- Don’t know what you got till it’s gone: microglial depletion and neurodegeneration
- Notice of Retraction
- Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia
- Protein post-translational modifications after spinal cord injury
- Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
- Axonal mRNA localization and local translation in neurodegenerative diseases
- Alzheimer’s disease: a tale of two diseases?
- Sleep disorders in Alzheimer’s disease: the predictive roles and potential mechanisms
- The plasminogen activating system in the pathogenesis of Alzheimer’s disease
- Corrigendum
- Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
- Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
- A paradigm shift: emerging roles of microglia, a non-neuronal cell, in learning and memory
- Slc7a5 regulation of neural development
- MicroRNA-based therapeutics for optic neuropathy: opportunities and challenges
- In vivo direct reprogramming as a therapeutic strategy for brain and retina repair
- Intravitreal fluorogold tracing as a method to label retinal neurons and the retinal pigment epithelium
- OTX2 signaling in retinal dysfunction,degeneration and regeneration
- Modulation of brainstem reflexes induced by non-invasive brain stimulation: is there a future?
- High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
- Regulating autophagy: a novel role for SETX (Senataxin)
- Biomarker-guided drug therapy:personalized medicine for treating Alzheimer’s disease
- How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
- Short-chain fatty acids in the context of Parkinson’s disease
- Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
- The dual role of necrostatin-1 in Parkinson’s disease models
- Potential role of biofeedback therapy for Parkinson’s disease
- Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
- Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
- Nuclear sphingomyelin in neurodegenerative diseases
- Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
- β2 and α2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine
- Role of circular RNA expression in the pathological progression after spinal cord injury
- Methylene blue enhances polyethylene glycol-fusion repair of completely severed rat sciatic nerves
- Exosomes derived from human induced pluripotent stem cell-derived neural progenitor cells protect neuronal function under ischemic conditions
- The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage
- Markers for neural degeneration and regeneration:novel highly sensitive methods for the measurement of thrombin and activated protein C in human cerebrospinal fluid
- Fluoxetine, a selective serotonin reuptake inhibitor used clinically, improves bladder function in a mouse model of moderate spinal cord injury
- MicroRNA and mRNA profiling of cerebral cortex in a transgenic mouse model of Alzheimer’s disease by RNA sequencing
- Luteolin delays photoreceptor degeneration in a mouse model of retinitis pigmentosa
- Combined treatment with valproic acid and estrogen has neuroprotective effects in ovariectomized mice with Alzheimer’s disease